Swedish company Quality Pharma is dedicated to bringing innovative technology to global healthcare. In response to the $1 trillion cost of Adverse Drug Reactions (ADRs) Quality Pharma have developed the QS software (Quantum Satis, Latin for “sufficient quantity”), a powerful and innovative AI platform to identify patterns and correlations in drug treatment, using regional, national, and international drug data sources. It combines health care and self-reported patient data to provide a personalised indication of potential cause for concern.
The QS software scans a database of over 9,000 medicines, providing medical professionals with the relevant information showing the potential risks of, and interactions between, different prescribed medicines. The patient also provides behavioural and symptomatic information to help the medical professional decide. The medical professional always makes the final decision after reviewing the results of the QS report and the information the patient provides.
Professor Johan Fastbom is the visionary whose algorithms empower the QS System® of Quality Pharma.
Johan gained his degree in medicine at Karolinska Institutet 1984 where in 1988 he also gained his PhD in pharmacology. During the period 1990-1994 he worked as a physician at the department of clinical pharmacology at Karolinska Hospital. Between 1992 and 1993 he was a house officer in internal medicine at Karlskoga hospital. In 1994 he became a specialist in clinical pharmacology at Karolinska University Hospital in Solna, and in 1998 an associate professor of geriatric pharmacology at Karolinska Institutet.
From 1994 to 2002 he was employed as a senior research fellow at the then Neurotec department, Karolinska Institutet, and from 2002 to 2011 as a senior lecturer at the Karolinska Institutet’s Aging Research Center (ARC), a position which still occupies most of his working hours. Johan Fastbom was appointed professor of geriatric pharmacology at Karolinska Institutet in 2011.
Learn more about Johan and Quality Pharma here